Specification BPC-157 TB-500 (Thymosin Beta-4) Cartalax (AED) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser Ala-Glu-Asp Molecular Formula C62H98N16O22 C212H350N56O78S C12H19N3O8 Molecular Weight 1419.5 g/mol 4963.4 g/mol 333.29 g/mol CAS Number 137525-51-0 77591-33-4 205640-90-0 PubChem CID 9941957 16132341 87815447 Synonyms Bepecin, Bpc 15, Body protection compound 15, Pentadecapeptide Thymosin Beta 4, Thymosin 4, TB500, Timbetasin T-31, AED, Alanyl-glutamyl-aspartic acid
This improvement in exercise capacity can lead to more effective workouts, which in turn can contribute to increased fat loss and muscle gain over time
Long-term safety data is limited for many peptides
Side Effects & Safety Profile GHK-Cu has one of the most favorable safety profiles in the peptide research literature, which is partly attributable to its endogenous nature it is a molecule the body already produces and recognizes
The key is consistency: hitting a meaningful protein target at each meal rather than trying to catch up at dinner
Figure 3 3.4 Epigenetic and signal transduction effects The regulation of epigenetics and the manipulation of signal transduction pathways have emerged as a fundamental mechanistic basis by which natural agents can exert strong anti-cancer effects in breast cancer, affecting the various stages of tumour development (initiation, progression, metastasis), and response to therapy by targeting diverse interactions between gene expression, chromatin structure, and intracellular signalling elements (198)